GBA1 and Parkinson disease: Supporting this, in vitro studies demonstrated that lipids isolated from fibroblasts of GBA1-PD patients carrying the p.L444P mutation enhance alpha-synuclein fibril formation, with EV membranes enriched in sphingolipids, ceramides known to mediate exosome biogenesis and cargo delivery.